Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting WALTHAM, Mass., May 1, 2015 – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic prod - Vascular endothelial growth factor A - Document - PDFSEARCH.IO

First Page	Meta Content
	Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting WALTHAM, Mass., May 1, 2015 – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic prod Add to Reading List Document Date: 2015-05-11 17:04:35 Open Document File Size: 210,70 KB Share Result on Facebook City Denver / WALTHAM / / Company Polaris Partners / Kala Pharmaceuticals Inc. / Third Rock Ventures / Lux Capital / Ysios Capital / / Event Funding / / IndustryTerm potential applications / biopharmaceutical engineering / stage pharmaceutical / ophthalmic products / / MedicalCondition respiratory and gastrointestinal diseases / ocular diseases / / Organization Crown Venture Fund / Association for Research / / ProvinceOrState Massachusetts / / PublishedMedium Ophthalmology / / Technology MPP technology / / URL www.kalarx.com / / SocialTag Tyrosine kinase Vascular endothelial growth factor Tyrosine-kinase inhibitor Medicine Ophthalmology Protein kinase inhibitor

Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting WALTHAM, Mass., May 1, 2015 – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic prodAdd to Reading List